The contribution of residues 192 and 193 to the specificity of snake venom serine proteinases

被引:34
作者
Braud, S
Parry, MAA
Maroun, R
Bon, C
Wisner, A
机构
[1] Inst Pasteur, Unite Venins, F-75724 Paris 15, France
[2] Max Planck Inst Biochem, Dept Struct Res, D-82152 Martinsried, Germany
关键词
D O I
10.1074/jbc.275.3.1823
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Snake venom serine proteinases, which belong to the subfamily of trypsin-like serine proteinases, exhibit a high degree of sequence identity (60-66%). Their stringent macromolecular substrate specificity contrasts with that of the less specific enzyme trypsin, One of them, the plasminogen activator from Trimeresurus stejnegeri venom (TSV-PA), which shares 63% sequence identity with batroxobin, a fibrinogen clotting enzyme from Bothrops atrox venom, specifically activates plasminogen to plasmin like tissue-type plasminogen activator (t-PA), even though it exhibits only 23% sequence identity with t-PA This study shows that TSV-PA, t-PA, and batroxobin are quite different in their specificity toward small chromogenic substrates, TSV-PA being less selective than t-PA, and batroxobin not being efficient at all, The specificity of TSV-PA, with respect to t-PA and batroxobin, was investigated further by site directed mutagenesis in the 189-195 segment, which forms the basement of the S-1 pocket of TSV-PA and presents a His at position 192 and a unique Phe at position 193, This study demonstrates that Phe(193) plays a more significant role than His(192) in determining substrate specificity and inhibition resistance. Interestingly, the TSV-PA variant F193G possesses a 8-9-fold increased activity for plasminogen and becomes sensitive to bovine pancreatic trypsin inhibitor.
引用
收藏
页码:1823 / 1828
页数:6
相关论文
共 29 条
  • [1] BERGMANN SR, 1983, SCIENCE, V220, P1181
  • [2] Bode W, 1983, Adv Exp Med Biol, V156, P289
  • [3] COLLEN D, 1991, BLOOD, V78, P3114
  • [4] COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77
  • [5] MUTATIONS AFFECTING THE ACTIVITY OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    DAVIDOW, LS
    DUMAIS, DR
    SMYTH, AP
    GREER, J
    MOIR, DT
    [J]. PROTEIN ENGINEERING, 1991, 4 (08): : 923 - 928
  • [6] CONVERTING TRYPSIN TO CHYMOTRYPSIN - THE ROLE OF SURFACE LOOPS
    HEDSTROM, L
    SZILAGYI, L
    RUTTER, WJ
    [J]. SCIENCE, 1992, 255 (5049) : 1249 - 1253
  • [7] IYANIWURA TT, 1991, VET HUM TOXICOL, V33, P475
  • [8] DETERMINATION OF OPERATIONAL MOLARITY OF SOLUTIONS OF BOVINE ALPHA-CHYMOTRYPSIN, TRYPSIN, THROMBIN AND FACTOR XA BY SPECTROFLUORIMETRIC TITRATION
    JAMESON, GW
    ROBERTS, DV
    ADAMS, RW
    KYLE, WSA
    ELMORE, DT
    [J]. BIOCHEMICAL JOURNAL, 1973, 131 (01) : 107 - 117
  • [9] The recombinant Escherichia coli-derived protease domain of tissue-type plasminogen activator is a potent and fibrin specific fibrinolytic agent
    Kohnert, U
    Hellerbrand, K
    Martin, U
    Stern, A
    Popp, F
    Fischer, S
    [J]. FIBRINOLYSIS, 1996, 10 (02) : 93 - 102
  • [10] The 2.3 angstrom crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator
    Lamba, D
    Bauer, M
    Huber, R
    Fischer, S
    Rudolph, R
    Kohnert, U
    Bode, W
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1996, 258 (01) : 117 - 135